LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Actinium Pharmaceuticals Inc

Închisă

1.81 8.38

Rezumat

Modificarea prețului

24h

Curent

Minim

1.62

Maxim

1.84

Indicatori cheie

By Trading Economics

Venit

-9.3M

-16M

EPS

-0.51

Angajați

31

EBITDA

-9.3M

-17M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+255.03% upside

Dividende

By Dow Jones

Următoarele câștiguri

1 aug. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

2.2M

51M

Deschiderea anterioară

-6.57

Închiderea anterioară

1.81

Actinium Pharmaceuticals Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

5 iun. 2025, 20:45 UTC

Câștiguri

Broadcom 2Q Sales Climb on Booming AI Demand

5 iun. 2025, 23:45 UTC

Market Talk

Nikkei May Decline as Caution Over U.S. Economy Continues -- Market Talk

5 iun. 2025, 23:44 UTC

Market Talk

Gold Edges Higher on Weak U.S. Data -- Market Talk

5 iun. 2025, 23:30 UTC

Market Talk

NZME Cost Cuts Can Cushion Effect of Weak Market -- Market Talk

5 iun. 2025, 21:32 UTC

Câștiguri

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 iun. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

5 iun. 2025, 20:45 UTC

Câștiguri

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 iun. 2025, 20:24 UTC

Câștiguri

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 iun. 2025, 20:15 UTC

Câștiguri

Broadcom 2Q Cont Ops EPS $1.03 >AVGO

5 iun. 2025, 20:15 UTC

Câștiguri

Broadcom 2Q Rev $15B >AVGO

5 iun. 2025, 20:15 UTC

Câștiguri

Broadcom 2Q Net $4.97B >AVGO

5 iun. 2025, 20:15 UTC

Câștiguri

Broadcom 2Q Adj EPS $1.58 >AVGO

5 iun. 2025, 20:15 UTC

Câștiguri

Broadcom 2Q EPS $1.03 >AVGO

5 iun. 2025, 20:15 UTC

Câștiguri

Broadcom Sees 3Q Rev $15.8B >AVGO

5 iun. 2025, 20:11 UTC

Achiziții, Fuziuni, Preluări

Constellation Energy: Transaction Is Expected to Close in the 4Q >CEG

5 iun. 2025, 20:11 UTC

Achiziții, Fuziuni, Preluări

Constellation Energy: Calpine Deal Clears Texas Regulatory Review

5 iun. 2025, 20:11 UTC

Achiziții, Fuziuni, Preluări

Constellation Energy: With Approval From PUCT Secured, Transaction Awaits Clearance From NY State Public Service Commission, Federal Energy Regulatory Commission and DOJ >CEG

5 iun. 2025, 19:22 UTC

Market Talk

Oil Futures Resume Upward Moves -- Market Talk

5 iun. 2025, 19:00 UTC

Market Talk

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

5 iun. 2025, 18:32 UTC

Market Talk

Gold Slips After Trump-Xi Call -- Market Talk

5 iun. 2025, 18:26 UTC

Câștiguri

These Stocks Are Moving the Most Today: Broadcom, Tesla, Circle, Brown-Forman, MongoDB, Planet Labs, ChargePoint, Ciena, and More -- Barrons.com

5 iun. 2025, 18:06 UTC

Market Talk

Transpacific Ship Freight Rates Spike on China Tariff Truce -- Market Talk

5 iun. 2025, 16:30 UTC

Achiziții, Fuziuni, Preluări

Vallourec Completes The Acquisition Of Thermotite Do Brasil >VK.FR

5 iun. 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

5 iun. 2025, 16:18 UTC

Market Talk

U.S. Natural Gas Market Shrugs Off Big Storage Build -- Market Talk

5 iun. 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

5 iun. 2025, 16:12 UTC

Market Talk

Global Energy Roundup: Market Talk

5 iun. 2025, 16:12 UTC

Market Talk

Copper Prices Rise on Positive Signals From Trump on China Trade Talks -- Market Talk

5 iun. 2025, 16:03 UTC

Market Talk

U.S. Diesel, Gasoline Futures Pick Back Up -- Market Talk

5 iun. 2025, 15:49 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Comparație

Modificare preț

Actinium Pharmaceuticals Inc Așteptări

Obiectiv de preț

By TipRanks

255.03% sus

Prognoză pe 12 luni

Medie 6 USD  255.03%

Maxim 9 USD

Minim 4 USD

În baza a 3 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruActinium Pharmaceuticals Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

3 ratings

3

Cumpărare

0

Păstrare

0

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Actinium Pharmaceuticals Inc

Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. Its Iomab-B is an induction and conditioning agent prior to bone marrow transplant in patients with relapsed and refractory acute myeloid leukemia (r/r AML). The company focuses on advancing its development for product candidate Actimab-A, a therapeutic agent that has demonstrated potential activity in r/r AML patients. In addition, it engages with the National Cancer Institute under the cooperative research and development agreement for the development of Actimab-A in AML and other myeloid malignancies. Its Iomab-ACT, a next generation conditioning candidate, is being developed for improving patient access and outcomes for curative cell and gene therapies. Further, the company's research and development activities primarily focus on advancing various preclinical programs for solid tumor indications. The company holds approximately 235 patents and patent applications, including various patents related to the manufacture of the isotope Ac-225 in a cyclotron. The company is based in New York, New York.